Patients with chronic heart failure (CHF) who have experienced a myocardial infarction (MI) will benefit from a -blocker

By  

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial

By Franzosi M.G.   Maggioni A.P.   Santoro E.   Tognoni G.   Cavalieri E.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 337-346

Adis International

Access to resources Recommend Favorite

Drug Treatment of Elderly Patients with Acute Myocardial Infarction: Practical Recommendations

By Aronow W.S.  

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 807-818

Adis International

Access to resources Recommend Favorite

For patients with acute anterior wall ST-segment elevation myocardial infarction (STEMI), early abciximab prior to angioplasty improves treatment outcomes

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Tilarginine does not reduce the risk of mortality for patients with acute myocardial infarction (MI) and cardiogenic shock

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite